Tamarack Advisers, LP Fennec Pharmaceuticals Inc. Transaction History

Tamarack Advisers, LP

  • $2.12 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$7.38 - $10.35 $470,844 - $660,330
-63,800 Reduced 29.95%
149,200 $1.24 Million
Q4 2022

Feb 10, 2023
BUY
$7.63 - $10.22 $289,940 - $388,360
38,000 Added 21.71%
213,000 $2.04 Million
Q3 2022

Nov 14, 2022
BUY
$5.71 - $8.54 $999,250 - $1.49 Million
175,000 New
175,000 $1.42 Million

Others Institutions Holding FENC

# of Institutions
63
Shares Held
14.8M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $169M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email